GLI1 and neoplasm: Active GLI proteins drive tumor formation and promote cancer progression by inducing proliferation, survival, self‐renewal and metastasis.7, 8 To target oncogenic HH/GLI signaling, small molecule SMO inhibitors (SMOi) have been developed.